- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06666023
Paper-based Electrochemical Point-of-care Device in Diagnostic of Orthopedic Infections (Ortho-PoC)
October 29, 2024 updated by: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
The Diagnostic Pillar for Diagnosis of Infections in the Orthopedic Field: Smart and Sustainable Paper-based Electrochemical Point-of-care Device Assisted by Artificial Intelligence
Periprosthetic Joint infections (PJI) and spondylodiscitis are considered some of the most costly infectious diseases because require at least one surgery, prolonged hospitalisation, rehabilitation care, prolonged antibiotherapy, and extended absence from work in working-age patients.
Ortho-PoC will face this issue with a smart and highly innovative diagnostic tool, starting from the point-of-care device for infection diagnosis in the orthopedic field developed and published by the coordinator Fondazione Policlinico Universitario Agostino Gemelli IRCCS and one partner Università degli Studi di Roma Tor Vergata.
Ortho-PoC will further go beyond the state of the art by delivering a point-of-care device based on multiparametric analysis, in easily collected synovial fluids or pus.
Several samples will be analysed using Ortho-PoC at three different Hospitals (Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Ospedali Riuniti di Foggia, Azienza Ospedaliera Universitaria Policlinico Vanvitelli Napoli) and the data will be treated with artificial intelligence (AI) to deliver an AI-assisted robust, effective, and smart diagnostic device for PJI.
Study Overview
Study Type
Observational
Enrollment (Estimated)
400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Raffaele Vitiello, MD PhD
- Phone Number: +39 - 0630151
- Email: raffaele.vitiello@policlinicogemelli.it
Study Locations
-
-
Lazio
-
Roma, Lazio, Italy, 00168
- Recruiting
- Fondazione Policlinico Gemelli IRCCS
-
Contact:
- Raffaele Vitiello, MD PhD
- Phone Number: +390630155701
- Email: raffaele.vitiello@policlinicogemelli.it
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Patients with a suspected history of PJI or spondylodiscitis according to international guidelines and subsequent diagnostic confirmation of infection.
Description
Inclusion Criteria:
- patients that received a joint implant or spine surgery, clear signs of infection (according to international guidelines)
- patients off antibiotic therapy at least for two weeks
- Sample biopsy of minimum 1 ml.
Exclusion Criteria:
- pregnant women,
- patient affected by cancer
- patient under antibiotic therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Infection Group
Patients affected by PJI and Spondylodiscitis
|
Use of the device in groups to test its ability to diagnose infections.
|
|
Control Group
Patients with post-contusive or inflammatory or arthritic suffusion
|
Use of the device in groups to test its ability to diagnose infections.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensitivity and Specificity
Time Frame: at enrollement
|
Most reliable cut-off evaluation in terms of best sensitivity and specificity of device in diagnosing PJI and spondylodiscitis
|
at enrollement
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Giulio Maccauro, Fondazione Policlinico Universitario A. Gemelli, IRCCS
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2024
Primary Completion (Estimated)
September 1, 2025
Study Completion (Estimated)
September 1, 2026
Study Registration Dates
First Submitted
October 29, 2024
First Submitted That Met QC Criteria
October 29, 2024
First Posted (Actual)
October 30, 2024
Study Record Updates
Last Update Posted (Actual)
October 30, 2024
Last Update Submitted That Met QC Criteria
October 29, 2024
Last Verified
September 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PNRR-POC-2023-12378291
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spondylodiscitis
-
Assiut UniversityNot yet recruitingSpinal Infection | Primary Spondylodiscitis | Pyogenic Spondylodiscitis
-
University Hospital, Clermont-FerrandRecruitingManagement of SpondylodiscitisFrance
-
Azienda Ospedaliera SS. Antonio e Biagio e Cesare...Active, not recruiting
-
Assiut UniversityRecruiting
-
Odense University HospitalSuspendedSpondylodiscitisDenmark
-
Federal State Budgetary Organization, Federal Center...CompletedSpondylitis | Osteomyelitis | Spondylodiscitis | Discitis | Pyogenic Infections | Spinal InfectionRussia
-
Yuzuncu Yıl UniversityCompleted
-
Nantes University HospitalCompletedVertebral Osteomyelitis | SpondylodiscitisFrance
-
Assistance Publique - Hôpitaux de ParisCompletedVertebral OsteomyelitisFrance
-
Assiut UniversityNot yet recruiting
Clinical Trials on Device
-
ResMedKlinEra Global ServicesNot yet recruitingObstructive Sleep ApneaAustralia
-
Facet TechnologiesLifeScanCompletedDiabetesUnited States
-
Karolinska InstitutetUnknownDegenerative Disc Disease | Discogenic Low Back PainSweden
-
AOTI Ltd.CompletedDiabetic Foot UlcerUnited Kingdom, United States, Germany, France, Luxembourg
-
Cala Health, Inc.Not yet recruiting
-
International Agency for Research on CancerUniversity of North Carolina Global Project Zambia; Liger Medical LlcCompleted
-
Universitair Ziekenhuis BrusselTerminated
-
University of BernDCB Research AG; Insel Gruppe AG, University Hospital BernCompletedGlucose Metabolism Disorders | Diabetes Mellitus | Endocrine System Diseases | Metabolic DiseaseSwitzerland
-
Neurive Co.,Ltd.CompletedTinnitus | Subjective TinnitusSouth Korea
-
Kasey PhiferThe National Centre for ElectroMagnetic Therapies CICCompletedUnspecified Trauma- and Stressor-Related DisorderUnited Kingdom